![Tomer Berkovitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomer Berkovitz
Direktor/Vorstandsmitglied bei
SOPHIA GENETICS SA
Profil
Tomer Berkovitz is currently an Independent Non-Executive Director at SOPHiA GENETICS SA since 2021, a Director at PrognomIQ, Inc. since 2020, and Managing Partner at aMoon Ventures Y Sh Ltd. since 2023.
Former positions include Director at Zebra Medical Vision Ltd. from 2018 to 2021, Chief Operating & Financial Officer at Alcobra Ltd. from 2014 to 2018, Executive Director in the Investment Banking Division at JPMorgan Chase Bank, NA (New York), Director at Mapi-Pharma Ltd., and General Partner at aMoon Fund.
Education includes undergraduate and graduate degrees from Tel-Aviv University and a doctorate from Columbia Business School.
Aktive Positionen von Tomer Berkovitz
| Unternehmen | Position | Beginn |
|---|---|---|
| SOPHIA GENETICS SA | Direktor/Vorstandsmitglied | 01.03.2021 |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Private Equity Investor | 01.02.2018 |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Direktor/Vorstandsmitglied | 15.09.2020 |
Ehemalige bekannte Positionen von Tomer Berkovitz
| Unternehmen | Position | Ende |
|---|---|---|
Zebra Medical Vision Ltd.
 Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Direktor/Vorstandsmitglied | 30.11.2021 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Finanzdirektor/CFO | 01.01.2018 |
aMoon Fund
 aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
| MAPI PHARMA LTD | Direktor/Vorstandsmitglied | - |
JPMorgan Chase Bank, NA (New York)
 JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Corporate Officer/Principal | - |
Ausbildung von Tomer Berkovitz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Finance |
Mapi-Pharma Ltd.
 Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops long acting depot injectable drugs | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
 SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Zebra Medical Vision Ltd.
Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Technology Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
aMoon Fund
aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
Wählen Sie MarketScreener 
